Advances in Precision Medicine for NSCLC: Expert Guidance for Community Practice

Download this living slideset from our live meeting series to gain expert insights on established and emerging biomarkers critical to optimal use of targeted therapy and immunotherapy in patients with NSCLC.
Zofia Piotrowska, MD, MHS
Karen L. Reckamp, MD, MS
Format: Microsoft PowerPoint (.ppt)
File Size: 1.51 MB
Released: September 26, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bayer HealthCare Pharmaceuticals Inc.
Genentech, a member of the Roche Group
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Lilly
Novartis Pharmaceuticals Corporation
Regeneron Pharmaceuticals, Inc.
Turning Point Therapeutics, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings